marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 13.11.2024
Taysha Gene Therapies Bilanz 2011-2024 | TSHA
Bilanz Jährlich Taysha Gene Therapies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-102 M | -48.7 M | -112 M | -251 M | - | - | - | - | - | - | - | - | - |
Langfristige Schulden |
40.5 M | 38 M | 37.2 M | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
1.29 M | 1.2 M | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 450 K | - | - | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
36.8 M | 62.8 M | 51.7 M | 7.13 M | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
97.8 M | 125 M | 119 M | 7.58 M | 150 K | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
18.1 M | 33.6 M | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-513 M | -401 M | -236 M | -61.1 M | -1.12 M | - | - | - | - | - | - | - | - |
Vermögenswerte |
173 M | 126 M | 214 M | 259 M | 15 K | - | - | - | - | - | - | - | - |
Zahlungsmittel |
144 M | 87.9 M | 149 M | 251 M | - | - | - | - | - | - | - | - | - |
Buchwert |
74.9 M | 949 K | 95.4 M | 251 M | -135 K | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
74.9 M | 949 K | 95.4 M | 251 M | -135 K | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Taysha Gene Therapies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
43 M | 37.8 M | 40.5 M | 40.5 M | 38.5 M | 38.4 M | 38.2 M | 38 M | 37.8 M | 37.6 M | 37.4 M | 37.2 M | 27.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
91.4 M | 91.5 M | 99.2 M | 97.8 M | 245 M | 119 M | 117 M | 125 M | 100 M | 110 M | 115 M | 119 M | 101 M | 55.4 M | 20 M | 7.58 M | 7.58 M | 7.58 M | 7.58 M | 150 K | 150 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
11.8 M | 13.6 M | 14.7 M | 18.1 M | 18.8 M | 20.2 M | 28.9 M | 33.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-584 M | -558 M | -537 M | -513 M | -561 M | -444 M | -419 M | -401 M | -346 M | -320 M | -286 M | -236 M | -185 M | -134 M | -93.2 M | -61.1 M | -61.1 M | -61.1 M | -61.1 M | -1.12 M | -1.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
180 M | 200 M | 153 M | 173 M | 196 M | 81.5 M | 102 M | 126 M | 111 M | 142 M | 166 M | 214 M | 241 M | 242 M | 243 M | 259 M | 259 M | 259 M | 259 M | 15 K | 15 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
158 M | 173 M | 124 M | 144 M | 164 M | 45.1 M | 63.4 M | 87.9 M | 34.3 M | 66.2 M | 96.6 M | 149 M | 189 M | 197 M | 229 M | 251 M | 251 M | 251 M | 251 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
88.8 M | 109 M | 53.8 M | 74.9 M | -49.1 M | -37.1 M | -14.9 M | 949 K | 11.1 M | 32.7 M | 50.7 M | 95.4 M | 140 M | 186 M | 223 M | 251 M | 251 M | 251 M | 251 M | -135 K | -135 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
88.8 M | 109 M | 53.8 M | 74.9 M | -49.1 M | -37.1 M | -14.9 M | 949 K | 10.7 M | 32.5 M | 50.7 M | 95.4 M | 140 M | 186 M | 223 M | 251 M | 251 M | 251 M | 251 M | -135 K | -135 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung